5 Most Promising Gene Therapy Companies to Watch

1. CRISPR Therapeutics AG (NASDAQ:CRSP)

Market Capitalization as of November 12, 2022: $4.72 billion

CRISPR Therapeutics AG (NASDAQ:CRSP) is a Swiss company that is perhaps the most renowned gene therapy company in the world. The firm’s CRISPR gene editing platform is synonymous with the industry, and this allows researchers to make direct changes to the gene sequence and DNA. CRISPR Therapeutics AG (NASDAQ:CRSP) is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG (NASDAQ:CRSP) is looking to complete the regulatory filings of its CTX001 treatment for sickle cell disease and thalassemia. The firm’s thalassemia treatment aims to have a price of $5 million and the price of its sickle cell treatment can go even higher. Additionally, CRISPR Therapeutics AG (NASDAQ:CRSP)’s thalassemia treatment alone is estimated to be worth a whopping $11 billion, making the math and future potential clear when CRISPR Therapeutics AG (NASDAQ:CRSP)’s market value of $4.72 billion is considered.

CRISPR Therapeutics AG (NASDAQ:CRSP)’s largest investor is Catherine D. Wood’s ARK Investment Management which owns 974 million shares that are worth $564 million.

Disclosure: None. You can also take a look at 15 Biggest Insurance Companies in the World and 10 Biggest Publishing Companies in the World.

Follow Insider Monkey on Twitter